title: Immunological parameters, including CXCL8 (IL-8) characterize cerebro- and cardiovascular events in patients with peripheral artery diseases.
abstract: The most commonly occurring atherosclerotic manifestations are peripheral artery diseases (PAD). Immune-mediated processes contribute to the development of atherosclerosis, and affect the diseases outcome. The aim of the present study was to assess various immune-competent cells, cytokines and chemokines in patients with PAD and to evaluate whether the base immunological values reflect the subsequent development of cardio/cerebrovascular symptoms. One hundred sixty patients with PAD were followed-up for 42 months. At the time of enrolment, we determined blood lymphocyte subpopulations, both T-helper (Th)1/Th2-type intracytoplasmic cytokines and soluble cytokines, chemokines. Intracellular cytokines were measured on phorbol-myristate-acetate- and ionomycine- stimulated cells. Lymphocyte subgroups were quantified by flow cytometry, soluble cytokines by ELISA and intracellular cytokine levels were measured by flow cytometry. The ankle-brachial index (ABI), indicator of atherosclerosis, was also evaluated. The clinical results were correlated with the immune-parameters to assess the input of immune-inflammatory events in the propagation of vascular manifestation. CD4(+) T-cell proportions in patients with PAD with cerebro- cardio-vascular manifestations were decreased, which further reduced in patients with fatal outcome. Of circulating chemokines, IL-8 (CXCL-8) was increased in patients with subsequent cerebro- cardio-vascular manifestations, compared to those without the symptoms, and further raised in patients with fatal outcome. The percentage of interferon (IFN)-gamma positive cells showed clear negative correlation with ABI. We conclude that altered peripheral lymphocyte subsets and cytokine/chemokine imbalance play important roles in the proinflammatory cascade and reflect disease severity in patients with PAD.
authors.affiliation: 3 Department of Medicine, Institute for Internal Medicine, Medical and Health Science Center, University of Debrecen, Debrecen, Hungary.
authors.forename: E
authors.initials: E
authors.lastname: Szomjak
authors.forename: H
authors.initials: H
authors.lastname: Der
authors.forename: G
authors.initials: G
authors.lastname: Kerekes
authors.forename: K
authors.initials: K
authors.lastname: Veres
authors.forename: L
authors.initials: L
authors.lastname: Csiba
authors.forename: J
authors.initials: J
authors.lastname: Toth
authors.forename: M
authors.initials: M
authors.lastname: Peter
authors.forename: P
authors.initials: P
authors.lastname: Soltesz
authors.forename: P
authors.initials: P
authors.lastname: Szodoray
mesh_terms: D002318:Cardiovascular Diseases / Q000150:complications / Q000276:immunology*; D002561:Cerebrovascular Disorders / Q000150:complications / Q000276:immunology*; D016207:Cytokines / Q000276:immunology; D005260:Female; D006801:Humans; D016209:Interleukin-8 / Q000276:immunology*; D008213:Lymphocyte Activation / Q000276:immunology; D008297:Male; D008875:Middle Aged; D016491:Peripheral Vascular Diseases / Q000150:complications / Q000276:immunology*; D012307:Risk Factors; D013601:T-Lymphocytes / Q000276:immunology
chemical_list: C508606:CXCL8 protein, human; D016207:Cytokines; D016209:Interleukin-8